Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Equity - Additional Information (Details)

v3.21.2
Shareholders' Equity - Additional Information (Details)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Feb. 02, 2021
USD ($)
Jan. 29, 2021
USD ($)
$ / shares
shares
Aug. 31, 2020
shares
Sep. 30, 2019
USD ($)
shares
Oct. 02, 2021
USD ($)
$ / shares
shares
Sep. 26, 2020
USD ($)
shares
Mar. 28, 2020
shares
Oct. 02, 2021
USD ($)
$ / shares
shares
Sep. 26, 2020
USD ($)
shares
Jan. 02, 2021
$ / shares
shares
Apr. 30, 2021
shares
Dec. 28, 2019
shares
Shareholders Equity [Line Items]                        
Common stock, shares authorized (in shares)         200,000,000     200,000,000   200,000,000    
Number of common stock returned to the company     71,607                  
Common stock, issued shares (in shares)         2,827,410     2,827,410   1,829,982    
Common stock, outstanding shares (in shares)         2,827,410     2,827,410   1,829,982    
Common stock par value | $ / shares         $ 0.001     $ 0.001   $ 0.001    
Options outstanding         120,500     120,500   113,900   44,400
Options granted               38,000   74,000    
Share-based compensation expense | $         $ 49,000     $ 275,000        
Preferred Stock outstanding         238,729     238,729   259,729    
Warrants outstanding         33,363     33,363   33,363    
Warrant exercise price | $ / shares         $ 3.40     $ 3.40   $ 3.40    
Warrant expiration date               2021-11   2021-11    
Stock Options                        
Shareholders Equity [Line Items]                        
Share-based compensation expense | $           $ 46,000     $ 118,000      
Unrecognized compensation expense, net of estimated forfeitures | $         $ 34,000     $ 34,000        
Unrecognized compensation expense, net of estimated forfeitures, period for recognition               2022-07        
2016 Plan                        
Shareholders Equity [Line Items]                        
Options expiration date               Oct. 28, 2026        
Options authorized for issuance         800,000     800,000        
Options outstanding         90,000     90,000   78,000    
2011 Plan                        
Shareholders Equity [Line Items]                        
Options expiration date             May 12, 2021          
Options outstanding         30,500     30,500   35,900    
Additional awards to be granted after adoption of 2016 plan             0          
Common Stock                        
Shareholders Equity [Line Items]                        
Number of shares converted to Common Stock                     420,000  
Preferred Stock, Convertible, Conversion Ratio                     0.05  
Common Stock | Equity Offering                        
Shareholders Equity [Line Items]                        
Common stock, shares authorized (in shares)   571,428                    
Common stock par value | $ / shares   $ 0.001                    
Common stock purchase price per share | $ / shares   $ 10.50                    
Common stock gross proceeds before deducting placement agent fees and offering expenses | $ $ 6,000,000.0                      
Common Stock | Equity Offering | Placement Agency Agreement                        
Shareholders Equity [Line Items]                        
Percentage of cash fee gross proceeds   7.00%                    
Common Stock | Equity Offering | Maximum | Placement Agency Agreement                        
Shareholders Equity [Line Items]                        
Gross proceeds reimbursement for accountable legal expenses | $   $ 35,000                    
Series A Preferred                        
Shareholders Equity [Line Items]                        
Number of shares converted                     21,000  
Preferred Stock outstanding         238,729     238,729   258,729    
Contractor                        
Shareholders Equity [Line Items]                        
Stock issued for services, shares       223,214         104,798      
Stock issued for services, value | $       $ 1,000,000.0         $ 351,000      
Articles of Incorporation                        
Shareholders Equity [Line Items]                        
Common stock, shares authorized (in shares)           200,000,000     200,000,000